Quick Answer
BriaCell Therapeutics Corp. reported Common Stock Shares Outstanding of 1.88 million shares for the year ending 2025.
- BriaCell Therapeutics Corp. showed an increase of +539.3% in Common Stock Shares Outstanding from 2025 to 2025.
- This data is from BriaCell Therapeutics Corp.'s annual report (Form 10-K), filed with the SEC on October 16, 2025.
- XBRL data for this metric is available from 2021 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2021 to 2025), BriaCell Therapeutics Corp.'s Common Stock Shares Outstanding has declined by 87.7%.
- Historical annual values: Fiscal year 2025: 1.88 million shares | Fiscal year 2025: 294,694 shares | Fiscal year 2024: 121,907 shares | Fiscal year 2023: 15.98 million shares | Fiscal year 2022: 15.52 million shares | Fiscal year 2021: 15.27 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: